Sleep Health Enhancement in Midlife Adults

December 18, 2025 updated by: University of Kansas Medical Center
Despite the strong links between sleep and AD, a sleep health enhancement has yet to be targeted in mid-life adults (45-64 years old) to delay or prevent AD. An intervention aimed at enhancing sleep health is a critical opportunity for primary prevention to potentially delay the onset of AD. The objective of the proposed study is to develop and assess the feasibility, acceptability, and treatment effect of a comprehensive sleep health intervention (SHI) on improving sleep health in mid-life adults

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kansas
      • Kansas City, Kansas, United States, 66160
        • University of Kansas Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 45-64 years old
  • ≤ 7 on the RU-SATED self-report questionnaire
  • MMSE ≥25 and AD8 <3

Exclusion Criteria:

  • Known untreated sleep disorder (such as sleep apnea or restless leg syndrome)
  • >3 on the STOP BANG indicating increased risk of sleep apnea
  • Increased risk of restless legs syndrome on RLS-Diagnosis Index
  • Evidence of circadian rhythm sleep-wake disorder
  • Evidence of parasomnia
  • Regular use (>2x/week) of prescription or over-the-counter medications to improve sleep
  • Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorsement of any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9)
  • Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety
  • Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-5-TR criteria
  • History of nervous system disorder such as stroke or Parkinson's disease
  • Severe mental illness such as schizophrenia or bipolar disorder
  • Current or history (within 5 years) of shift work including hours of midnight-4am
  • Is currently receiving a behavioral sleep health intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep Health Enhancement Intervention
4 weekly visits using Zoom video conferencing consisting of education and strategies to enhance sleep health with each visit lasting about 60 minutes.
4 weekly visits of education and strategies to enhance sleep health
No Intervention: Wait-List Control Group
People in the wait-list group will continue with their usual activities for 4 weeks and then start the sleep health enhancement intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-item Acceptability Scale
Time Frame: immediately post-intervention
5-point Likert scales on ease of use, understandability, enjoyment, perceived helpfulness, time commitment, and overall satisfaction
immediately post-intervention
Qualitative interview
Time Frame: immediately post-intervention
semi-structured interview to assess acceptability
immediately post-intervention
Ru-SATED Composite score
Time Frame: baseline, Week 6, Week 12
Comprised of 6 subscores (regularity, timing, efficiency, and duration from actigraphy, satisfaction from sleep diary, and alertness from Epworth Sleepiness Scale)
baseline, Week 6, Week 12
Sleep Self-Efficacy Scale
Time Frame: baseline, Week 6, Week 12
9 item self-report Likert-scale questionnaire use to identify sleep self-efficacy.
baseline, Week 6, Week 12
Pittsburgh Sleep Quality Index
Time Frame: baseline, Week 6, Week 12
used to assess quality of sleep
baseline, Week 6, Week 12
Epworth Sleepiness Scale
Time Frame: baseline, Week 6, Week 12
used to assess daytime sleepiness
baseline, Week 6, Week 12
Dysfunctional Beliefs About Sleep (DBAS-10) consists of 10 statements reflecting beliefs and attitudes about sleep. Each statement is rated from 1 = strongly disagree to 10 = strongly agree
Time Frame: baseline, Week 6, Week 12
The DBAS-10 used to identify dysfunctional beliefs about sleep
baseline, Week 6, Week 12
Positive Affect and Negative Affect Schedule
Time Frame: baseline, Week 6, Week 12
20-item self-report questionnaire used to measure positive and negative emotions
baseline, Week 6, Week 12
Continuous Performance Test
Time Frame: baseline, Week 6, Week 12
requires participants to respond as quickly and accurately as possible to a series of stimuli that are delivered via computer. The participants will be instructed to tap the space bar for every letter except "X."
baseline, Week 6, Week 12
Stroop Test
Time Frame: baseline, Week 6, Week 12
requires participants to inhibit the natural response (reading a word) and replace it with another response (saying a color)
baseline, Week 6, Week 12
Cognitive Failures Questionnaire
Time Frame: baseline, Week 6, Week 12
assesses perception of cognitive abilities over the past 6 months
baseline, Week 6, Week 12
Actigraphy
Time Frame: baseline, Week 6, Week 12
Participants will wear an actigraph on their non-dominant wrist for 7 nights to assess sleep/wake cycle. Mains variables of interest are sleep regularity, timing, efficiency, and duration.
baseline, Week 6, Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2024

Primary Completion (Actual)

November 19, 2025

Study Completion (Actual)

November 19, 2025

Study Registration Dates

First Submitted

January 12, 2024

First Submitted That Met QC Criteria

March 7, 2024

First Posted (Actual)

March 15, 2024

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00151143

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe